Carrimycin Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Modulating Gut Microbiota and Restoring Th17/Treg Balance
Carrimycin effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by suppressing systemic inflammation, restoring the Th17/Treg immune balance, and reconstructing the gut microbiota composition.